These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 27884454)
1. [Management of adverse effects related to human immunoglobulin therapy: Recommendations for clinical practice]. Marie I; Chérin P; Michallet M; Pelus E; Dantal J; Crave JC; Delain JC; Viallard JF Rev Med Interne; 2017 May; 38(5):312-319. PubMed ID: 27884454 [TBL] [Abstract][Full Text] [Related]
2. Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence. Cherin P; Marie I; Michallet M; Pelus E; Dantal J; Crave JC; Delain JC; Viallard JF Autoimmun Rev; 2016 Jan; 15(1):71-81. PubMed ID: 26384525 [TBL] [Abstract][Full Text] [Related]
3. Adverse Effects of Immunoglobulin Therapy. Guo Y; Tian X; Wang X; Xiao Z Front Immunol; 2018; 9():1299. PubMed ID: 29951056 [TBL] [Abstract][Full Text] [Related]
4. Adverse events associated with intravenous immunoglobulin therapy. Hamrock DJ Int Immunopharmacol; 2006 Apr; 6(4):535-42. PubMed ID: 16504916 [TBL] [Abstract][Full Text] [Related]
6. Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review. Abbas A; Rajabally YA Curr Drug Saf; 2019; 14(1):3-13. PubMed ID: 30332974 [TBL] [Abstract][Full Text] [Related]
7. Adverse effects of human immunoglobulin therapy. Stiehm ER Transfus Med Rev; 2013 Jul; 27(3):171-8. PubMed ID: 23835249 [TBL] [Abstract][Full Text] [Related]
9. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Schiavotto C; Ruggeri M; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756 [TBL] [Abstract][Full Text] [Related]
10. Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience. Kaba S; Keskindemirci G; Aydogmus C; Siraneci R; Erol Cipe F Eur Ann Allergy Clin Immunol; 2017 Jan; 49(1):11-14. PubMed ID: 28120600 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin Replacement Therapy for Primary Immunodeficiency. Sriaroon P; Ballow M Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315 [TBL] [Abstract][Full Text] [Related]
12. Managing patients with side effects and adverse events to immunoglobulin therapy. Azizi G; Abolhassani H; Asgardoon MH; Shaghaghi S; Negahdari B; Mohammadi J; Rezaei N; Aghamohammadi A Expert Rev Clin Pharmacol; 2016; 9(1):91-102. PubMed ID: 26496172 [TBL] [Abstract][Full Text] [Related]
13. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease. Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654 [TBL] [Abstract][Full Text] [Related]
14. Call for guidelines for monitoring renal function and haematological variables during intravenous infusion of immunoglobulin in neurological patients. Bajaj NP; Henderson N; Bahl R; Stott K; Clifford-Jones RE J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):562-3. PubMed ID: 11561055 [No Abstract] [Full Text] [Related]